Open AccessMorphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies
Author(s) -
Neha Chopra Narang,
Usha Rusia,
Meera Sikka,
Mrinalini Kotru
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/25173.9650
Subject(s) - medicine , myelofibrosis , imatinib mesylate , bone marrow , imatinib , biopsy , myeloid leukemia , gastroenterology , myeloid , surgery , pathology
Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with reference to myelofibrosis.